August 25th, 2020
Harvard University, AbbVie form research alliance to address emergent viral diseases
Commitment of $30M from AbbVie supports research collaboration with Harvard Medical School to advance development of therapeutics
News
Press Contact: Kirsten Mabry | (617) 495-4157
Featured Tags:
August 21st, 2020
Torus Biosystems to pioneer Wyss Institute's comprehensive infectious disease diagnostics platform at patient point-of-care
Nucleic acid detection technology facilitates precision diagnostics
August 11th, 2020
July 2020 patents
Innovations in tubular tissue engineering, treating pain, fabrication of soft machines, quantum metrology, human genome editing, and more
July 22nd, 2020
A versatile vessel for next-gen therapeutics
Harvard’s ARMMs technology to be commercialized by Vesigen Therapeutics for targeted intracellular delivery of large-molecule drugs
July 21st, 2020
Tough gel technology licensed to Amend Surgical for oral surgery applications
Medical device company will pursue development of strong, biocompatible adhesive that could replace sutures and dental membranes
